Previous 10 | Next 10 |
GUILFORD, Conn., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the creator of Swoop®, the world's first FDA-cleared portable MRI system™, today reported financial results for the quarter ended June 30, 2022. Management will host a corresponding conference cal...
Virax Biolabs Group ( VRAX ) +40% on launch of real-time PCR test for monkeypox in Europe. 36Kr Holdings ( KRKR ) +14% . InflaRx ( IFRX ) +12% Plans to Apply for Emergency Use Authorization from the US FDA for Vilobelimab for Treatment of Crit...
GUILFORD, Conn., July 20, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the creator of Swoop®, the world's first FDA-cleared portable MRI system™, today announced that it will report financial results for the second quarter 2022 on Wednesday, August 10, 2022. Comp...
AUSTIN, Texas, July 14, 2022 (GLOBE NEWSWIRE) -- Today, at HA Connect!, the 17th annual national conference on hydrocephalus, Hyperfine—creator of Swoop ®, the first FDA-cleared portable magnetic resonance imaging (MRI) device—announced a new software enhancement ...
The following slide deck was published by Hyperfine, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: Hyperfine, Inc. 2022 Q1 - Results - Earnings Call Presentation
Hyperfine, Inc. (HYPR) Q1 2022 Earnings Conference Call May 11, 2022, 04:30 PM ET Company Participants Marissa Bych - Gilmartin Group IR Dave Scott - President and CEO Alok Gupta - CFO Conference Call Participants Lawrence Biegelsen - Wells Fargo Vijay Kumar - Evercore ISI Presentation Operat...
Hyperfine press release (NASDAQ:HYPR): Q1 GAAP EPS of -$0.34 misses by $0.13. Revenue of $1.51M (+357.6% Y/Y) beats by $0.51M. For further details see: Hyperfine GAAP EPS of -$0.34 misses by $0.13, revenue of $1.51M beats by $0.51M
GUILFORD, Conn., May 11, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the creator of Swoop®, the world's first FDA-cleared portable MRI system™, today reported financial results for the quarter ended March 31, 2022. Management will host a corresponding conference cal...
GUILFORD, Conn., April 20, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the creator of Swoop®, the world's first FDA-cleared portable MRI system™, today announced that it will report financial results for the first quarter 2022 on Wednesday, May 11, 2022. Company...
The following slide deck was published by Hyperfine, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Hyperfine, Inc. 2021 Q4 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
The total number of Hyperfine AI-powered marketing authorizations places the company in a leading position on recently published FDA list. Hyperfine (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared porta...
The publication includes a subset of data from the ACTION PMR stroke study and provides early evidence that the Swoop ® system is a promising tool for enabling critical stroke treatment choices in urgent care settings. Hyperfine (Nasdaq: HYPR), the groundbreaking health technol...
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced that it will report financial results for the second ...